Pulse Biosciences posts updated investor presentation on website; no new financial data disclosed

PULSE BIOSCIENCES, INC.

Updated deck highlights progress on CellFX nsPFA 360 Cardiac Catheter, Cardiac Surgery System, and Percutaneous Electrode.
Investor presentation is dated August 2024 and available on company's website.
No specific milestones, clinical data, or financial guidance included in filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.